Organogenesis Holdings (ORGO) Revenue (2017 - 2026)

Organogenesis Holdings' Revenue history runs 10 years deep, the most recent figure standing at $37.2 million for Q1 2026.

• In Q1 2026, Revenue fell 57.06% year-over-year to $37.2 million; the TTM figure through Mar 2026 stood at $514.7 million (up 12.19% YoY), while the FY2025 annual figure was $564.2 million, up 17.04% from the prior year.
• Revenue was $37.2 million for Q1 2026 at Organogenesis Holdings, down from $225.6 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $225.6 million in Q4 2025 to a low of $37.2 million in Q1 2026.
• Historically, Revenue has averaged $115.7 million across 5 years, with a median of $115.2 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Revenue surged 78.13% in 2025, then sank 57.06% in 2026.
• A 5-year view of Revenue shows it stood at $115.5 million in 2022, then retreated by 13.73% to $99.7 million in 2023, then advanced by 27.1% to $126.7 million in 2024, then jumped by 78.13% to $225.6 million in 2025, then tumbled by 83.5% to $37.2 million in 2026.
• The last three Revenue figures came in at $37.2 million (Q1 2026), $225.6 million (Q4 2025), and $150.9 million (Q3 2025), per Business Quant data.